Back to MACKENZIE FINANCIAL CORP MACKENZIE FINANCIAL CORP

TBPHTBPH
5 quarters

Position history for MACKENZIE FINANCIAL CORPMACKENZIE FINANCIAL CORP's holdings in THERAVANCE BIOPHARMA INC

MACKENZIE FINANCIAL CORP holds 985,848 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $16.8M as of 2026-Q2. The position was increased (+296.4% shares). TBPH represents 0.0% of MACKENZIE FINANCIAL CORP's portfolio.

Current Value

$16.8M

Current Shares

985,848

Total Value Change

+$16M

Total Shares Change

+951,938

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
985,848
+296.4%
$16.8M0.0%$17.00
46
2026-Q1
Increased
248,682
+566.2%
$4M0.0%$13.96
43
2025-Q4
New
37,329
-
$704,5030.0%$18.91
34
2020-Q2
Exited
0
-100.0%
$00.0%$20.64
0
2020-Q1
New
33,910
-
$784,0000.0%$23.06
34

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used